Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BBIO

BridgeBio Pharma Inc

Jun 18 • 04:00PM ET

66.27

-1.12 -1.66 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: ASND BMRN MDGL ALNY IONS KRYS EXEL RARE ARWR VRTX

| Held by: VTI VB IWM VBK VXF XBI IWO IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.75	Insider Own	13.65%	Shs Outstand	195.71M	Perf Week	-1.89%
Market Cap	12.98B	Forward P/E	122.68	EPS next Y	0.54	Insider Trans	-2.82%	Shs Float	169.13M	Perf Month	0.41%
Enterprise Value	15.43B	PEG	-	EPS next Q	-0.58	Inst Own	91.41%	Short Float	14.42%	Perf Quarter	-5.42%
Income	-721.55M	P/S	22.38	EPS this Y	42.66%	Inst Trans	4.70%	Short Ratio	9.76	Perf Half Y	-12.45%
Sales	579.96M	P/B	-	EPS next Y	124.92%	ROA	-64.06%	Short Interest	24.39M	Perf YTD	-13.36%
Book/sh	-11.64	P/C	13.80	EPS next 5Y	-	ROE	-	52W High	84.94 -21.98%	Perf Year	65.67%
Cash/sh	4.80	P/FCF	-	EPS past 3/5Y	-5.07% 0.09%	ROIC	-135.35%	52W Low	39.65 67.14%	Perf 3Y	341.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	86.30% 127.44%	Gross Margin	94.69%	Volatility	3.30% 3.90%	Perf 5Y	8.05%
Dividend TTM	-	EV/Sales	26.61	EPS Y/Y TTM	-6.09%	Oper. Margin	-86.94%	ATR (14)	2.71	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.48	Sales Y/Y TTM	355.17%	Profit Margin	-124.41%	RSI (14)	45.42	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	1.52	EPS Q/Q	4.35%	SMA20	-1.31%	Beta	0.97	Target Price	104.16
Payout	-	Debt/Eq	-	Sales Q/Q	66.78%	SMA50	-4.87%	Rel Volume	1.53	Prev Close	67.39
Employees	839	LT Debt/Eq	-	Earnings	May 07 AMC	SMA200	-1.89%	Avg Volume	2.50M	Price	66.27
IPO	Jun 27, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.75% 9.24%	Trades		Volume	3,814,245	Change	-1.66%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)